Maine Medicine Weekly Update - 12/17/2020  (Plain Text Version)

Return to Graphical Version

 

In this issue:
•  Advisory Panel Recommends Moderna Vaccine, FDA Expected to Authorize Emergency Use
•  Update to Our Special Edition Wednesday Vaccine Newsletter
•  FDA Authorizes First OTC COVID-19 Test
•  Maine Public Radio Reports 32 COVID-19 Cases Linked To Bangor Hospital Outbreak
•  MaineCare Section 17 Assertive Community Treatment (ACT) Service Cap
•  Attention FQHCs and RHCs: Reimbursing Telehealth Services, CR 98696
•  Current FDA Drug Shortages
•  Not Much COVID Relief Movement from Congress
•  Maine CDC Physicians To Host Regular Clinician COVID Vaccine Info Sessions
•  PPE Available Through the MMA & ActionPPE
•  Maine Medical Association Enduring Education Opportunity
•  MICIS Opioid Prescribing Presentation & Individual Academic Detailing Sessions
•  Hanley's PELI Advanced Course Enrollment is OPEN!
•  A Message from Maine Responds: Volunteer Opportunity
MAINE LEGISLATURE
•  State Legislative Committees Announced
UPCOMING EVENTS
•  Upcoming Specialty Society Programs & Meetings
•  Webinar: “Radon Risk Reduction: The Current Policy Landscape in the US and the Maine Perspective” January 12, 2020
•  Caring for LGBTQ+ Youth in Maine - Emphasis on the 'T' - Half-day Symposium on Saturday, January 23
•  MOA VIRTUAL Midwinter Symposium - Feb 12-14, 2021
•  Maine CDC Annual Prevention Professionals Conference - March 2-3, 2021
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Behavioral Health Clinician
•  Psychiatric Nurse Practitioner
•  Physician (BC/BE in Family Medicine)

 

FDA Authorizes First OTC COVID-19 Test

A viral antigen over-the-counter COVID-19 home test that can be used without a prescription was authorized for emergency use this week by the FDA. Patients perform their own nasal swab and a smartphone app helps interpret results without sending it to a lab.

 

A viral antigen over-the-counter COVID-19 home test that can be used without a prescription wasauthorized for emergency use this week by the FDA. Patients perform their own nasal swab and a smartphone app helps interpret results without sending it to a lab. 

The FDA authorization comes on the heels of authorization last month of the first prescription COVID-19 test for home use. 

Coronavirus (COVID-19) Update: FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19